Neurodegeneración
DTI-ALPS as a marker of glymphatic function: Review of the literature findings, methodology, and interpretation
Glymphatic system role in cerebrospinal fluid (CSF) circulation and waste clearance in the brain. CSF enters the brain along periarterial spaces, facilitated by aquaporin-4 (AQP4) water channels located on astrocyte end feet. The CSF then mixes with interstitial fluid (ISF) in the brain interstitial space, aiding in the removal of soluble amyloid-beta (Ab) and other metabolic waste products. This mixture is driven through the brain tissue by bulk flow and exits via perivenous spaces, ultimately being transported to lymphatic vessels for elimination. (From (Botta et al., 2025)).
Fuente oficial abierta: NCBI/PMC (PMC13474630)
Non-Invasive Assessment of Glymphatic Clearance via DTI-ALPS: Molecular Mechanisms, AQP4 Dysregulation, and Sex-Dimorphic Dynamics in Neurodegeneration
Abstract
The glymphatic system represents a macro-fluidic clearance network responsible for eliminating metabolic waste products—including amyloid-beta ($\text{A}\beta$), hyperphosphorylated tau, and $\alpha$-synuclein—from the central nervous system parenchyma. Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS) has emerged as a validated, non-invasive magnetic resonance imaging (MRI) method to quantify glymphatic transport capacity by evaluating water diffusivity within the deep white matter perivascular spaces. At the cellular level, efficient glymphatic flux depends on astrocytic aquaporin-4 (AQP4) water channels polarized to perivascular endfeet and driven by arterial pulsations. Impairments in AQP4 polarization and vascular compliance yield aberrant DTI-ALPS metrics, signaling early neurodegenerative pathogenesis. Crucially, recent sex-and-gender-based analyses (SGBA) demonstrate marked sex-dimorphic trajectories in glymphatic decline. Estrogen signaling influences astrocytic homeostatic functions and microvascular compliance, rendering post-menopausal females uniquely vulnerable to accelerated glymphatic failure and subsequent proteinopathy. This review elucidates the biophysical and molecular principles underpinning the DTI-ALPS metric, delineates the neurobiological cascades governing astrocytic AQP4 channel dynamics, and emphasizes the necessity of incorporating sex-stratified analytical frameworks into precision neuroimaging and therapeutic design for neurodegenerative diseases.
Introduction & Cellular Mechanisms
The central nervous system (CNS) lacks a conventional lymphatic lymphatic drainage network within its parenchymal architecture. Instead, global metabolic waste clearance is accomplished via the glymphatic system—a specialized glia-mediated convective interstitial fluid (ISF) and cerebrospinal fluid (CSF) exchange pathway. CSF enters the brain parenchyma through periarterial influx routes, driven by hydrostatic gradients generated by cardiac cycles and arterial smooth muscle tone. This influx traverses the astrocytic endfeet, mixes with the parenchymal ISF, and facilitates the clearance of neurotoxic metabolic byproducts into the perivenous spaces, ultimately draining into the dural lymphatics and cervical lymph nodes.
```
[Periarterial Influx (CSF)]
│
▼
[Astrocytic Endfeet (Polarized AQP4)]
│
▼
[Convective CSF-ISF Exchange] ──► Clears: Aβ, Tau, α-synuclein
│
▼
[Perivenous Outflux (ISF)]
```
At the cellular and subcellular level, the rate-limiting molecular node of glymphatic flux is the transmembrane water channel Aquaporin-4 (AQP4), highly enriched at the foot processes of protoplasmic and fibrous astrocytes. AQP4 is densely clustered within hydrophobic membrane domains anchored by the dystrophin-associated protein complex (DAPC), which includes $\alpha$-syntrophin and dystrobrevin. Highly polarized perivascular AQP4 drastically reduces hydraulic resistance across the astrocytic syncytium, facilitating rapid, directional movement of water driven by osmotic and hydrostatic pressure differentials.
In neurodegenerative conditions—such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and cerebral small vessel disease (CSVD)—astrogliosis disrupts this precise spatial organization. Reactive astrogliosis induces the loss of perivascular AQP4 localization (depolarization), redirecting AQP4 channels diffusely across the astrocytic soma. This molecular displacement disrupts directional fluid transudation, exacerbating parenchymal solute stagnation and accelerating the deposition of aggregation-prone proteins.
```
Healthy State: Neurodegenerative State:
Periarterial Space Periarterial Space
└── Astrocytic Endfoot └── Reactive Astrocyte
└── [AQP4 Clustered (High Flux)] └── [AQP4 Depolarized / Diffuse (Low Flux)]
```
To measure this physiological process non-invasively, Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS) was developed. DTI-ALPS evaluates water motion in deep white matter tracts at the level of the lateral ventricle body. In this specific anatomical region, medullary veins and their surrounding perivascular spaces run perpendicular to both the projection fibers (orientated along the Z-axis, superior-inferior) and association fibers (orientated along the Y-axis, anterior-posterior). By calculating the ratio of diffusivities along the direction of the perivascular spaces (X-axis, medial-lateral) relative to diffusivities perpendicular to both main fiber tracts ($D_{xx}$ relative to $D_{yy}$ and $D_{zz}$), the ALPS index isolatedly measures water movement strictly along the perivascular space, providing a sensitive, direct proxy for glymphatic function and parenchymal clearance capacity.
Sex-Dimorphic Regulation & Translational Implications
Translational research increasingly indicates that glymphatic transport and AQP4-dependent clearance are modulated by biological sex. Dissecting these biological differences is essential for establishing precision diagnostics and therapeutic interventions in neurodegeneration.
1. Estrogen-Mediated AQP4 Polarization and Astrocytic Plasticity
$17\beta$-estradiol ($E_2$) exerts direct control over astrocytic biology via Estrogen Receptor Alpha ($\text{ER}\alpha$) and Estrogen Receptor Beta ($\text{ER}\beta$). $E_2$ signaling maintains structural integrity at the blood-brain barrier (BBB) and stabilizes the DAPC, thereby preserving high-density AQP4 polarization at astrocytic endfeet. Age-related loss of circulating $E_2$ during menopause accelerates AQP4 depolarization, leading to an abrupt reduction in convective CSF-ISF exchange in females. DTI-ALPS imaging reflects this transition, demonstrating a steeper, age-correlated decline in the ALPS index in post-menopausal females compared to age-matched males.
2. Vascular Compliance and Arterial Pulsatility Dimorphism
Because glymphatic influx relies heavily on arterial wall pulsations, sex-specific differences in arterial stiffness directly alter glymphatic driving pressure. Females display distinct microvascular aging trajectories, characterized by a higher prevalence of small vessel disease and microvascular wall remodeling. This arterial stiffening attenuates pulsatile energy transfer across the perivascular space, decreasing fluid momentum. DTI-ALPS quantifies this hemodynamic compromise, yielding lower ALPS indices in females presenting with elevated arterial pulse wave velocity and white matter hyperintensity loads.
3. Sex-Specific Proteinopathy Dynamics and Diagnostic Sensitivity
The pathological consequences of diminished glymphatic flux differ by biological sex. In females, degraded glymphatic clearance synergistic with $E_2$ deprivation accelerates hyperphosphorylated tau accumulation and cortical spreading. Conversely, males exhibit early glymphatic compromise linked to arterial rigidity and neuroinflammation, driving earlier perivascular deposition of $\alpha$-synuclein in subcortical structures. DTI-ALPS serves as a vital neuroimaging biomarker capable of capturing these sex-specific functional impairments before irreversible, gross structural atrophy becomes detectable via conventional structural MRI.
```
Biological Sex ──► Hormonal / Vascular Drivers ──► Glymphatic Pathology (DTI-ALPS Metrics)
─────────────────────────────────────────────────────────────────────────────────────────────────
Females ──► Post-menopausal E2 Loss & ──► Rapid AQP4 depolarization; accelerated
Microvascular Stiffening tau clearance failure; steep DTI-ALPS drop
Males ──► Macro-vascular Rigidity & ──► Early perivascular α-synuclein deposition;
Chronic Neuroinflammation gradual DTI-ALPS decline
```
Conclusions & Clinical Outlook
The DTI-ALPS index offers a sensitive, clinically translatable window into the molecular and physiological health of the glymphatic system. By capturing subtle alterations in perivascular diffusivity, DTI-ALPS bridges the gap between basic cellular neurobiology—specifically AQP4 polarization and astrocytic endfoot homeostasis—and clinical neuroimaging.
Future precision medicine strategies must establish standardized, sex-stratified normative reference ranges for the DTI-ALPS index across diverse age cohorts. Clinically, DTI-ALPS holds high utility as a therapeutic monitoring tool to track candidate pharmacotherapies aimed at restoring AQP4 polarization (e.g., small-molecule AQP4 modulators), enhancing sleep-dependent glymphatic clearance, or targeting sex-hormone receptor signaling pathways in the early stages of neurodegenerative disease.